Advertisement
Singapore markets closed
  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     
  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • Bitcoin USD

    64,387.92
    +1,181.18 (+1.87%)
     
  • CMC Crypto 200

    1,379.88
    +67.26 (+5.12%)
     
  • S&P 500

    4,983.25
    -27.87 (-0.56%)
     
  • Dow

    37,986.98
    +211.60 (+0.56%)
     
  • Nasdaq

    15,368.70
    -232.80 (-1.49%)
     
  • Gold

    2,414.40
    +16.40 (+0.68%)
     
  • Crude Oil

    83.60
    +0.87 (+1.05%)
     
  • 10-Yr Bond

    4.6250
    -0.0220 (-0.47%)
     
  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     
  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     
  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

Is Gilead Sciences a Good Stock to Buy Now?

Is Gilead Sciences a Good Stock to Buy Now?

Shares of Gilead Sciences (NASDAQ: GILD) marched higher on Thursday, Feb. 2 in response to a fourth-quarter earnings report that exceeded expectations. A day later, the U.S. Food and Drug Administration (FDA) agreed to dramatically increase the addressable patient population for an important cancer drug called Trodelvy. Gilead Sciences splashed out with a $21 billion acquisition of Immunomedics in 2020 for access to Trodelvy.